| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7306799 |
Use of VEGF inhibitors for treatment of eye disorders |
Dec. 11, 2007 |
| 7304034 |
Use of HMGB fragments as anti-inflammatory agents |
Dec. 4, 2007 |
| 7304032 |
CD-10 activated prodrug compounds |
Dec. 4, 2007 |
| 7304031 |
Methods and means for producing proteins with predetermined post-translational modifications |
Dec. 4, 2007 |
| 7304030 |
Matrix protein composition for dentin regeneration |
Dec. 4, 2007 |
| 7304029 |
Neuroprotective effect of growth hormone |
Dec. 4, 2007 |
| 7303871 |
Enzyme treatment of foodstuffs for Celiac Sprue |
Dec. 4, 2007 |
| 7303814 |
Immobilized bioactive hydrogel matrices as surface coatings |
Dec. 4, 2007 |
| 7303755 |
Pharmaceutical compositions with antibiotic activity |
Dec. 4, 2007 |
| 7303748 |
Method of treating eye injury with local administration of a VEGF inhibitor |
Dec. 4, 2007 |
| 7303747 |
Use of VEGF inhibitors for treatment of eye disorders |
Dec. 4, 2007 |
| 7303746 |
Methods of treating eye disorders with modified chimeric polypeptides |
Dec. 4, 2007 |
| 7300918 |
Method of producing vaccines from protein signal oligopeptides |
Nov. 27, 2007 |
| 7300917 |
Remedy for chronic disease |
Nov. 27, 2007 |
| 7300916 |
Preventives/remedies for thickened scar, keloid or chronic arthritic diseases |
Nov. 27, 2007 |
| 7300915 |
Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain |
Nov. 27, 2007 |
| 7300762 |
Fluorescent proteins and methods of using same |
Nov. 27, 2007 |
| 7300666 |
Mixture for transdermal delivery of low and high molecular weight compounds |
Nov. 27, 2007 |
| 7300663 |
Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers |
Nov. 27, 2007 |
| 7300654 |
Method of treating corneal transplant rejection in high risk keratoplasty patients |
Nov. 27, 2007 |
| 7300653 |
Method of treating corneal transplant rejection |
Nov. 27, 2007 |
| 7300647 |
Hair care compositions |
Nov. 27, 2007 |
| 7297689 |
Method for preparing peritoneal dialysate |
Nov. 20, 2007 |
| 7297678 |
Use of repeat sequence protein polymers in personal care compositions |
Nov. 20, 2007 |
| 7297677 |
Method of improving the skin barrier function of a pet |
Nov. 20, 2007 |
| 7297676 |
Thymosin alpha 1 peptide/polymer conjugates |
Nov. 20, 2007 |
| 7297475 |
Medicament injection kit and medicament injection method |
Nov. 20, 2007 |
| 7297337 |
EphA2 T-cell epitopes and uses therefor |
Nov. 20, 2007 |
| 7294614 |
Phosphoprotein affinity resins and methods for making and using the same |
Nov. 13, 2007 |
| 7294613 |
Beta-defensins |
Nov. 13, 2007 |
| 7294339 |
Method for treating allodynia by peripheral administration of a neurotoxin |
Nov. 13, 2007 |
| 7291596 |
Pharmaceutical composition for thrombin peptide derivatives |
Nov. 6, 2007 |
| 7291590 |
Compositions and methods for treating atherosclerosis |
Nov. 6, 2007 |
| 7291589 |
Uses of human Zven proteins and polynucleotides |
Nov. 6, 2007 |
| 7291588 |
Immunogenic detoxified mutant E. coli LT-A toxin |
Nov. 6, 2007 |
| 7291587 |
Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
Nov. 6, 2007 |
| 7291344 |
Method for treating phantom pain by peripheral administration of a neurotoxin |
Nov. 6, 2007 |
| 7291333 |
Blockade of protein C activation reduces microvascular surgical blood loss |
Nov. 6, 2007 |
| 7288523 |
Peptide binding the KLVFF-sequence of amyloid-.beta. |
Oct. 30, 2007 |
| 7288517 |
Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists |
Oct. 30, 2007 |
| 7288516 |
Null IGF for the treatment of cancer |
Oct. 30, 2007 |
| 7288406 |
Active variants of FGF with improved specificity |
Oct. 30, 2007 |
| 7288260 |
Method for treating pain by peripheral administration of a neuroptoxin |
Oct. 30, 2007 |
| 7288259 |
Treatment of holocrine gland dysfunction with clostridia neurotoxins |
Oct. 30, 2007 |
| 7288253 |
Antibodies directed to parathyroid hormone (PTH) and uses thereof |
Oct. 30, 2007 |
| 7285534 |
Corticotropin-releasing hormone analogs and their uses |
Oct. 23, 2007 |
| 7285532 |
Therapeutic method for treating bone formation diseases |
Oct. 23, 2007 |
| 7285531 |
Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor |
Oct. 23, 2007 |
| 7285530 |
Use of SERP-1 as an antiplatelet agent |
Oct. 23, 2007 |
| 7285529 |
Embedder compositions and methods for detecting and killing cells in acidic areas of tumors |
Oct. 23, 2007 |
|
|
|
